Shao-lee Lin - Net Worth and Insider Trading

Shao-lee Lin Net Worth

The estimated net worth of Shao-lee Lin is at least $16 Million dollars as of 2024-05-12. Shao-lee Lin is the CEO of Acelyrin Inc and owns about 3,452,329 shares of Acelyrin Inc (SLRN) stock worth over $16 Million. Details can be seen in Shao-lee Lin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shao-lee Lin has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).

Transaction Summary of Shao-lee Lin

To

Shao-lee Lin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shao-lee Lin owns 6 companies in total, including Principia Biopharma Inc (PRNB) , Horizon Therapeutics PLC (HZNP) , and Surrozen Inc (SRZN) among others .

Click here to see the complete history of Shao-lee Lin’s form 4 insider trades.

Insider Ownership Summary of Shao-lee Lin

Ticker Comapny Transaction Date Type of Owner
PRNB Principia Biopharma Inc 2020-09-28 director
HZNP Horizon Therapeutics PLC 2018-01-04 EVP & Head of R&D and CSO
SRZN Surrozen Inc 2021-08-11 director
2021-08-11 director
2022-09-14 director
2024-04-01 director & Chief Executive Officer

Shao-lee Lin Latest Holdings Summary

Shao-lee Lin currently owns a total of 1 stock. Shao-lee Lin owns 3,452,329 shares of Acelyrin Inc (SLRN) as of April 1, 2024, with a value of $16 Million.

Latest Holdings of Shao-lee Lin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SLRN Acelyrin Inc 2024-04-01 3,452,329 4.68 16,156,900

Holding Weightings of Shao-lee Lin


Shao-lee Lin Form 4 Trading Tracker

According to the SEC Form 4 filings, Shao-lee Lin has made a total of 3 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Acelyrin Inc is the sale of 9,961 shares on April 1, 2024, which brought Shao-lee Lin around $66,041.

Insider Trading History of Shao-lee Lin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shao-lee Lin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shao-lee Lin Ownership Network

Ownership Network List of Shao-lee Lin

No Data

Ownership Network Relation of Shao-lee Lin


Shao-lee Lin Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

Shao-lee Lin is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Principia Biopharma Inc Insider Transactions

No Available Data

Shao-lee Lin Mailing Address

Above is the net worth, insider trading, and ownership report for Shao-lee Lin. You might contact Shao-lee Lin via mailing address: C/o Acelyrin, Inc., 4149 Liberty Canyon Rd., Agoura Hills Ca 91301.

Discussions on Shao-lee Lin

No discussions yet.